Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in
ESBL
Escherichia coli
UTI
fosfomycin
mecillinam
nitrofurantoin
outpatients
primary care
uropathogen
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
31 May 2022
31 May 2022
Historique:
received:
12
04
2022
revised:
20
05
2022
accepted:
24
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Urinary tract infections (UTIs) are among the most common bacterial infections in humans.
Identifiants
pubmed: 35740157
pii: antibiotics11060751
doi: 10.3390/antibiotics11060751
pmc: PMC9220249
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Apogepha Arzneimittel (Germany)
ID : No number provided.
Références
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30917983
J Antimicrob Chemother. 2006 Feb;57(2):367-8
pubmed: 16354745
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31332059
Dtsch Arztebl Int. 2018 Jul 23;115(29-30):494-500
pubmed: 30135009
Euro Surveill. 2020 Jun;25(25):
pubmed: 32613940
J Antimicrob Chemother. 2000 Aug;46 Suppl A:9-14
pubmed: 10969046
J Clin Microbiol. 2014 May;52(5):1358-65
pubmed: 24501035
Antimicrob Agents Chemother. 2015 Mar;59(3):1718-27
pubmed: 25583718
Clin Microbiol Infect. 2011 Dec;17(12):1845-51
pubmed: 21880098
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Int J Antimicrob Agents. 2014 Oct;44(4):295-300
pubmed: 25223936
EBioMedicine. 2017 Sep;23:111-118
pubmed: 28855073
J Antimicrob Chemother. 2022 Feb 2;77(2):381-390
pubmed: 34865035
Eur Urol. 2008 Nov;54(5):1164-75
pubmed: 18511178
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Nat Rev Urol. 2015 Oct;12(10):570-84
pubmed: 26334085
J Glob Antimicrob Resist. 2019 Jun;17:25-34
pubmed: 30447337
J Antimicrob Chemother. 2014 Oct;69(10):2873-5
pubmed: 24917584
Antimicrob Agents Chemother. 1976 May;9(5):793-9
pubmed: 949176
Aktuelle Urol. 2017 May;48(3):243-247
pubmed: 28427111
Int J Antimicrob Agents. 2020 Feb;55(2):105851
pubmed: 31770624